Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
08/14/2003 | US20030153751 Inhibitors of phospholipase enzymes |
08/14/2003 | US20030153613 Hypotensive agents for eye, using an aclurea indole compounds, potassium channel blockers; glaucoma |
08/14/2003 | US20030153611 Antitumor agents promoting the detachment of endothelial cells forming tumor, inhibiting tubulin polymerization |
08/14/2003 | US20030153604 Anticoagulants |
08/14/2003 | US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
08/14/2003 | US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists |
08/14/2003 | US20030153576 Such as amino-indazoles for treatment of central nervous system disorders |
08/14/2003 | US20030153560 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors |
08/14/2003 | US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
08/14/2003 | DE19933313C2 Mittel und Verfahren zur Färbung von Haaren Compositions and methods for dyeing hair |
08/14/2003 | CA2474532A1 Sulfonate derivatives and the use therof as latent acids |
08/14/2003 | CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
08/14/2003 | CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
08/13/2003 | EP1334719A2 Pentafluorobenzenesulfonamides and analogs |
08/13/2003 | EP1334083A2 1,4-disubstituted benzenes as insecticides |
08/13/2003 | EP1333832A1 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors |
08/13/2003 | EP1333824A2 Treatment of sexual dysfunction |
08/13/2003 | EP1178987B1 Substituted benzoylisoxazoles and the use thereof as herbicides |
08/13/2003 | EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
08/13/2003 | EP0891328B1 Peptidyl compounds having mmp and tnf inhibitory activity |
08/13/2003 | CN1117731C Benzo-pentaheterocyclic ring sulfonyl urea compound, its preparation method and herbicide using said compound as active component |
08/12/2003 | US6605721 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors |
08/12/2003 | US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid |
08/12/2003 | US6605632 Affinity for melatonin receptors |
08/12/2003 | US6605626 Antithrombotic agents |
08/12/2003 | US6605615 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
08/12/2003 | US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
08/07/2003 | WO2003064433A1 Polymerization catalyst activator and its use in a polymerization process |
08/07/2003 | WO2003064392A1 Process for the manufacture of hmg-coa reductase inhibitors |
08/07/2003 | WO2003064388A2 Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
08/07/2003 | WO2003064387A2 Substituted indoles as alpha-1 agonists |
08/07/2003 | WO2003064384A2 Environment friendly reagents and process for trifluoromethylsulfinylation of organic compounds |
08/07/2003 | WO2003064373A1 Triarylamine derivatives and the use thereof in organic electroluminescent and electrophotographic devices |
08/07/2003 | WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
08/07/2003 | WO2003010361A3 Nitrogen atom transfer |
08/07/2003 | WO2002048150A3 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
08/07/2003 | US20030149073 Cycloalkano-indole and -azaindole derivatives |
08/07/2003 | US20030149050 Inhibitors of inflammation and reperfusion injury and methods of use thereof |
08/07/2003 | US20030149048 For therapy of hyperproliferative disorder in a mammal |
08/07/2003 | US20030149047 Novel compounds |
08/07/2003 | US20030149029 Administering to a mammal indole derivative compound for therapy of asthma |
08/07/2003 | US20030149018 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
08/07/2003 | US20030148877 Metallocenes and catalysts for olefin-polymerisation |
08/07/2003 | CA2474595A1 Polymerization catalyst system and its use in a polymerization process |
08/07/2003 | CA2473803A1 Substituted indoles as alpha-1 agonists |
08/07/2003 | CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
08/06/2003 | EP1333026A1 Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
08/06/2003 | EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
08/06/2003 | EP1332131A2 Acid derivatives useful as serine protease inhibitors |
08/06/2003 | EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
08/06/2003 | EP1331935A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
08/06/2003 | CN1434819A 4-phenyl-peiperazinyl,-piperidinyl and -Tetrahydropyridyl derivatives |
08/06/2003 | CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use |
08/05/2003 | US6603006 Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use |
08/05/2003 | US6602890 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease |
08/05/2003 | CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
08/05/2003 | CA2077708C Cyclic nitrones |
07/31/2003 | WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection |
07/31/2003 | WO2003062200A2 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
07/31/2003 | WO2003062186A1 Metal salts of (3s)-3-methoxycarbonyl-4-phenylbutyric acid and usage thereof |
07/31/2003 | WO2003061660A1 Melanocortin receptor agonists |
07/31/2003 | WO2003020677A3 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments |
07/31/2003 | WO2002062762A3 Potassium channel openers |
07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
07/31/2003 | US20030144526 Calcium receptor-active compounds |
07/31/2003 | US20030144520 Inhibit p38- alpha kinase using compounds of the formula and the pharmaceutically acceptable salts thereof, or a pharmaceutical composition thereof, wherein noninterfering substituent; |
07/31/2003 | US20030144504 Dialkyl-halogenophenyl-substituted ketoenols |
07/31/2003 | US20030144339 Treatment of inflammatory disease, arthritis, asthma |
07/31/2003 | US20030144338 Pyrrole derivative |
07/31/2003 | US20030144323 Phenylalkynes |
07/31/2003 | US20030144282 Inhibitors of cytosolic phospholipase A2 |
07/31/2003 | US20030144278 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
07/31/2003 | US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same |
07/31/2003 | US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
07/31/2003 | US20030144272 Heterocyclic amines such as 2-(2-(N-Methylsulfamoyl)-4-methoxy -phenyl)-N-methyl-N-((1S)-1-phenyl-2-((1-pyrrolidinyl)ethyl)) acetamide, administered as analgesics |
07/31/2003 | US20030144267 Novel compounds |
07/31/2003 | US20030144265 HIV protease inhibitors based on amino acid derivatives |
07/31/2003 | US20030143699 Process for the preparation of optically active azabicyclo heptanone derivatives |
07/31/2003 | US20030143422 [5]-helicene and dibenzofluorene materials for use in organic light emitting devices |
07/31/2003 | US20030140820 Pigmented vitreous material |
07/31/2003 | CA2473036A1 Melanocortin receptor agonists |
07/30/2003 | EP1331222A1 Environment friendly reagents and process for halogenoalkylsulfinylation of organic compounds |
07/30/2003 | EP1331005A1 Medicinal compositions for concominant use as anticancer atent |
07/30/2003 | EP1330457A2 Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists |
07/30/2003 | EP1330435A1 Crystalline forms of fluvastatin sodium |
07/30/2003 | EP1330430A2 Integrin receptor inhibitors |
07/30/2003 | EP1330426A1 Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
07/30/2003 | EP1330233A1 Method of treating stroke |
07/30/2003 | EP1189885B1 Process for the synthesis of a-nor-seco compounds with sterane skeleton |
07/30/2003 | EP0592439B1 Aminosulfonyl carbamates |
07/30/2003 | CN1433411A Chemical compounds |
07/30/2003 | CN1433403A Solid pharmaceutical preparation |
07/29/2003 | US6600074 Perfluoroalkylated aniline compound and process for producing the same |
07/29/2003 | US6600039 Using potassium-t-butylate in tetrahydrofuran. it is not easy to carry out the process under industrial conditions, yield is low, the product is contaminated, its purification requires repeated crystallization. that by stirring in dimethyl |
07/29/2003 | US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity |
07/29/2003 | US6599929 1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
07/29/2003 | US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
07/29/2003 | CA2056065C Preparation of 3-alkylated indoles |
07/25/2003 | CA2369271A1 Light-induced modification of indole and trytophan |
07/24/2003 | WO2003059900A1 Coumarin derivatives, process for their production and use thereof |